LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
===================================================================================================================

* Landon C Brown
* Matthew D Tucker
* Ramy Sedhom
* Eric B Schwartz
* Jason Zhu
* Chester Kao
* Matthew K Labriola
* Rajan T Gupta
* Daniele Marin
* Yuan Wu
* Santosh Gupta
* Tian Zhang
* Michael R Harrison
* Daniel J George
* Ajjai Alva
* Emmanuel S Antonarakis
* Andrew J Armstrong